1 unchanged sentence
10b5-1 Trading Plans
−Removed: During the three months ended September 30, 2025, n o n e of our directors or officers, as defined in Rule 16a-1(f), informed us of the adoption, modification or termination of a “Rule 10b5-1 trading agreement” or “non-Rule 10b-51 trading agreement,” as those terms are defined in Regulations S-K, Item 408.
+Added: During the three months ended March 31, 2026, none of our directors or officers, as defined in Rule 16a-1(f), informed us of the adoption , modification or termination of a “Rule 10b5-1 trading agreement” or “non-Rule 10b5-1 trading agreement,” as those terms are defined in Regulations S-K, Item 408.
The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index below.
Filed/Furnished
−Removed: Amended and Restated Certificate of Incorporation of Passage Bio, Inc, as amended .
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
19 unchanged sentences
PASSAGE BIO, INC.
−Removed: November 10, 2025
/s/ William Chou, M.D.
1 unchanged sentence
President and Chief Executive Officer
−Removed: November 10, 2025
/s/ Kathleen Borthwick
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.